Translated automatically – community improvements welcome.
Felbamate
Felbamate is an anticonvulsant primarily used in treatment-resistant epilepsies. It acts by blocking sodium channels and antagonistic modulation of NMDA receptors, leading to the inhibition of excitatory neurotransmission. Due to potential severe side effects such as aplastic anemia and liver damage, it is used with caution. Felbamate exhibits neuroprotective properties and also affects GABAergic systems.
Mechanism of Action
- Natriumkanalblockade
- NMDA-Rezeptorantagonismus
Names / Identifiers
IUPAC: Felbamate
Mechanism of Action
Felbamat wirkt als Modulator des NMDA-Rezeptors und hat zusätzlich eine hemmende Wirkung auf bestimmte GABA-Rezeptoren, was zu einer Reduktion der neuronalen Erregbarkeit führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Severe liver disease
- Allergy to Felbamate
Known Risks
- high
- Potenzielle schwerwiegende Nebenwirkungen, einschließlich Leberfunktionsstörungen.
Safer Use
- Regular medical monitoring
- Avoidance of alcohol
- Informing about possible side effects
Harm reduction tips do not replace medical advice.
Known Interactions
- Other anticonvulsants
- Alcohol
- Medications that affect liver metabolism
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.